The World Health Organization targets global elimination of hepatitis C by 2030, aiming for a 90% reduction in new cases and a 65% drop in mortality, and testing is pivotal to achieving this goal. Here, Pathology in Practice Science Editor Brian Nation looks at recent published work in this area.
Global Elimination of Hepatitis C Virus
Fleurence RL, Alter HJ, Collins FS, Ward JW. Annu Rev Med. 2025 Jan; 76 (1): 29–41. doi: 10.1146/annurev-med-050223-111239.
Hepatitis C virus (HCV) is predominantly transmitted through parenteral exposures to infectious blood or body fluids. In 2019, approximately 58 million people worldwide were infected with HCV, and 290,000 deaths occurred due to hepatitis C-related conditions, despite hepatitis C being curable. There are substantial barriers to elimination, including the lack of widespread point-of-care diagnostics, cost of treatment, stigma associated with hepatitis C, and challenges in reaching marginalised populations, such as people who inject drugs.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.